Similarly, BIM protein increased eight-fold upon RAS inactivation and three-fold upon BCR-ABL inactivation in the Eμ -tTA/TRE-RAS and Eμ-tTA/TRE-BCR-ABL leukemia, respectively (Figure 2B–2C). This evidence concerns the gene BCL2L11 and leukemia.